0 false false false false false false false false false false true false false false false false false No description of principal activity 2024-04-01 Sage Accounts Production Advanced 2025 - FRS102_2025 xbrli:pure xbrli:shares iso4217:GBP 10199561 2024-04-01 2025-03-31 10199561 2025-03-31 10199561 2024-03-31 10199561 2023-04-01 2024-03-31 10199561 2024-03-31 10199561 2023-03-31 10199561 core:PlantMachinery 2024-04-01 2025-03-31 10199561 bus:Director2 2024-04-01 2025-03-31 10199561 core:WithinOneYear 2025-03-31 10199561 core:WithinOneYear 2024-03-31 10199561 core:ShareCapital 2025-03-31 10199561 core:ShareCapital 2024-03-31 10199561 core:RetainedEarningsAccumulatedLosses 2025-03-31 10199561 core:RetainedEarningsAccumulatedLosses 2024-03-31 10199561 bus:Director1 2024-04-01 2025-03-31 10199561 bus:SmallEntities 2024-04-01 2025-03-31 10199561 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 10199561 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 10199561 bus:EntityHasNeverTraded 2024-04-01 2025-03-31 10199561 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 10199561 bus:FullAccounts 2024-04-01 2025-03-31 10199561 core:OtherGroupMember1 2024-04-01 2025-03-31 10199561 core:OtherGroupMember1 2025-03-31 10199561 core:OtherGroupMember1 2024-03-31 10199561 core:KeyManagementIndividualGroup1 2024-04-01 2025-03-31 10199561 core:KeyManagementIndividualGroup1 2025-03-31 10199561 core:KeyManagementIndividualGroup1 2024-03-31
COMPANY REGISTRATION NUMBER: 10199561
Bioganix Generation Limited
Filleted Unaudited Financial Statements
For the year ended
31 March 2025
Bioganix Generation Limited
Statement of Financial Position
31 March 2025
2025
2024
Note
£
£
£
£
Current assets
Cash at bank and in hand
100
19,982
Creditors: amounts falling due within one year
4
34,579
54,461
--------
--------
Net current liabilities
34,479
34,479
--------
--------
Total assets less current liabilities
( 34,479)
( 34,479)
--------
--------
Net liabilities
( 34,479)
( 34,479)
--------
--------
Capital and reserves
Called up share capital
100
100
Profit and loss account
( 34,579)
( 34,579)
--------
--------
Shareholders deficit
( 34,479)
( 34,479)
--------
--------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 30 December 2025 , and are signed on behalf of the board by:
Mr L M Dodds
Director
Company registration number: 10199561
Bioganix Generation Limited
Notes to the Financial Statements
Year ended 31 March 2025
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Bonby Lane, Bonby, Brigg, DN20 0PJ.
2. Statement of compliance
These financial statements have been prepared in compliance with FRS 102, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
3. Accounting policies
(a) Basis of preparation
The financial statements have been prepared on the historical cost basis. The financial statements are prepared in sterling, which is the functional currency of the entity. The balance sheet at 31 March 2025 shows that liabilities exceeded assets by £34,479. Liabilities include loans from related group companies and shareholders totalling £33,188. The company relies on the continued support of the related group companies and shareholders to continue normal trading activities. Such support has been confirmed and will be made available for the foreseeable future and increased where necessary. The accounts are therefore prepared on the going concern basis.
(b) Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
(c) Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Plant and machinery
-
10% straight line
(d) Financial instruments
Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as either financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
4. Creditors: amounts falling due within one year
2025
2024
£
£
Amounts owed to group undertakings
29,781
25,646
Accruals and deferred income
1,391
1,391
Social security and other taxes
17,424
Director loan accounts
3,407
10,000
--------
--------
34,579
54,461
--------
--------
5. Related party transactions
During the year, the company was in receipt of a loan from a fellow subsidiary company. The loan is interest free and repayable on demand . At the year end date, the balance owing to the fellow subsidiary totalled £ 29,781 (2024 - £ 25,646 ). During the year, the company was in receipt of a loan from a director . The loan is interest free and repayable on demand . At the year end date the balance due to the director totalled £ 3,407 (2024 - £ 10,000 ).
6. Controlling party
The parent company is Bioganix (Holdings) Ltd , a company registered in England and Wales. The registered office address of Bioganix (Holdings) Ltd is Bonby Lane, Bonby, Brigg, North Lincolnshire, DN20 0PJ.